ArticleCureus2025
Corticosteroid Injections for Pain Relief and Range of Motion in Adhesive Capsulitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mid-term outcomes after corticosteroid injection for adhesive capsulitis in patients with type-2 diabetes: a retrospective cohort study.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
objectiveAdhesive capsulitis (frozen shoulder) is a chronic, painful shoulder condition characterized by progressive stiffness and restricted range of motion. Despite its prevalence, there is limited evidence, particularly in our regional population, regarding the optimal timing, dosage, and technique of corticosteroid injection to achieve maximal pain relief and functional recovery. The objective of this study was to evaluate the efficacy of intra-articular corticosteroid injections in patients with adhesive capsulitis, as measured by pain reduction and improvement in range of motion (ROM). Efficacy was defined as a reduction in pain exceeding the minimal clinically important difference (MCID) of 1.5 points on the visual analog scale (VAS) and an improvement in ROM of at least 20° in forward flexion or external rotation compared to baseline at the 12-week follow-up.
methodsThis quasi-experimental study was conducted at the Orthopedic and Spine Department, Khyber Teaching Hospital, Peshawar, from January 5, 2024, to July 5, 2024. A total of 148 patients of both genders with adhesive capsulitis were included. After using aseptic technique, a solution containing 80 mg/mL Depo-Medrol and 2% lignocaine was injected into the affected shoulder joint via a posterior approach using a blind technique. Patients were followed weekly for 12 weeks. Efficacy was assessed at the end of the follow-up period, based on pain relief and improvement in range of motion. No adjuvant therapy, such as physiotherapy, was administered during the study period.
resultsThe mean age of the patients was 48.99±10.03 years, with a mean BMI of 25.07±2.06 kg/m², a baseline VAS score of 6.12±1.21, and an average symptom duration of 13.17±5.06 weeks. At the end of the 12-week follow-up period, efficacy was defined as pain relief and improvement in range of motion, which were achieved in 53.4% of patients.
conclusionIntra-articular corticosteroid injections are moderately effective in the treatment of adhesive capsulitis, with just over half of the patients experiencing positive outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.